Loading asset research
MAIA Biotechnology Inc. Common Stock
MAIANYSE · USD · StocksQuote as of · Exchange session not verified$1.29
-1.53%
Today
MAIA
Loading 1D prices…
Market cap
$79.1M
Volume
681.4K
52w high
$3.1952w low
$0.87Company profile
MAIA Biotechnology Inc. Common Stock
MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
NYSE
Display currency
USD
Location
Chicago, IL, United States
Employees
13
Fiscal year end
1231
CIK
1878313
Session & valuation
Open$1.32
Previous close$1.31
Day high$1.32
Day low$1.27
30-day avg. volume379.2K
Outstanding shares60.8M
Diluted EPS-$0.70
Latest annual period
P/E (trailing)-1.84
P/E (forward)1.17
Price / book3.82
Beta0.26
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| RNXTRenovoRx Inc. Common Stock | $79.4M | $1.1M | -994.48% | -$0.32 | -0.56% | Buy |
| OSTXOS Therapies Incorporated Common Stock | $78.6M | $0.00 | — | -$0.98 | -7.69% | Buy |
| TELOTelomir Pharmaceuticals Inc. Common Stock | $80.5M | $0.00 | — | -$0.33 | -0.85% | Unrated |
| IBIOiBio Inc. Common Stock | $77.5M | $100K | -33044.00% | -$0.32 | -0.38% | Buy |
| INCRIntercure Ltd. Ordinary Shares | $77.4M | — | — | -$1.36 | -1.53% | Unrated |